Educational Tools

Biosimilars

• FDA’s Overview of the Regulatory Guidance for the Development and Approval of Biosimilar Products in the US
• Biosimilar Product Information
• Prescribing Biosimilar and Interchangeable Products

Breast Cancer

• CDK4/6 inhibition in breast cancer: current practice and future directions
• Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer
• History and future of targeting cyclin-dependent kinases in cancer therapy
• Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers
• Breast Cancer Treatment – Patient Information

Colorectal Cancer

• ESMO Consensus Guidelines for the Management of Patients with Metastatic Colorectal Cancer
• ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes
• Screening for Colorectal Cancer US Preventive Services Task Force Recommendation Statement
• BASIC (BLI Adenoma Serrated International Classification) classification for colorectal polyp characterization with blue light imaging
• The adenoma miss rate of blue-laser imaging vs. white-light imaging during colonoscopy
• Magnifying endoscopy simple diagnostic algorithm for early gastric cancer (MESDA-G).
• Adenoma detection rate: in search of quality improvement, not just measurement
• Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
• Genetic/Familial High-Risk Assessment: Colorectal v3.2017
• Microsatellite Instability - Defective DNA Mismatch Repair: ESMO Biomarker Factsheet
• DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics
• Get Tested for Colon Cancer [video for patients]
• National Cancer Institute: Colorectal Cancer [patient version]
• National Cancer Institute: Colorectal Cancer [health professional version]
• National Cancer Institute: Drugs Approved for Colon and Rectal Cancer

Head and Neck Cancer

• The value of immunotherapy in head and neck cancer
• Blue Laser Imaging-Bright Improves Endoscopic Recognition of Superficial Esophageal Squamous Cell Carcinoma
• Molecular Interactions and Expression of PD-1 and PD-L1
• Checkpoint Inhibitors Targeting PD-1 vs PD-L1

Hematologic Malignancies

• Multiple Myeloma Disease Overview
• Multiple Myeloma – Treatment Overview for Patients and Caregivers
• Stem Cell Transplantation for Multiple Myeloma – for Patients
• Treatment for Multiple Myeloma – for Health Professionals
• World Federation of Hemophilia Guidelines for the Management of Hemophilia

Hemophilia

• World Federation of Hemophilia Guidelines for the Management of Hemophilia

Hepatocellular carcinoma

• Hepatocellular Carcinoma: ESMO-ESDO Clinical Practice Guidelines
• Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread
• NCCN. Hepatobiliary Cancers v4. 2017
• Multidisciplinary approach for HCC patients: hepatology for the oncologists

Leukemia

• Rai and Binet Systems for Clinical Staging of CLL

Lung Cancer

• Molecular Interactions and Expression of PD-1 and PD-L1
• Checkpoint Inhibitors Targeting PD-1 vs PD-L1

Melanoma

• Nivolumab Nurses’ Checklist
• Ipilimumab Nurses’ Checklist
• Melanoma Treatment – for health professionals
• Melanoma Risk Assessment Tool
• Patients Educational Tool – Skin Cancer: Frequently Asked Question
• Molecular Interactions and Expression of PD-1 and PD-L1
• Checkpoint Inhibitors Targeting PD-1 vs PD-L1
• Combination Therapy: Nivolumab + Ipilimumab
• Immunotherapy for Melanoma Skin Cancer
• Targeted Therapy for Melanoma

Myelodysplastic Syndromes

• About Myelodysplastic Syndromes (MDS)
• Detailed Guide on MDS
• How are myelodysplastic syndromes staged?
• Treating MDS Toolkit
• The Diagnostic Spectrum of MDS, MDS/MPN, and MF Reference Card
• What is MDS? iPad App

Non-Small Cell Lung Cancer (NSCLC)

• Article: NCCN Guidelines Insights: Malignant Pleural Mesothelioma
• Biomarker discussion in National Comprehensive Cancer Network (NCCN) Quick Guide for Lung Cancer
• National Comprehensive Cancer Network (NCCN) Guidelines for Treatment of Cancer by Site
• Patients Educational Tool ─ Lung Cancer: Frequently Asked Questions
• Lung Cancer Screening Guidelines and Recommendations
• Questions to Ask Your Doctor: Non-Small Cell Lung Cancer - Patient Handout
• Understanding Non-Small Cell Lung Cancer - Patient Handout